Bank of America made $6.7 billion of profit in the fourth quarter of 2024, more than doubling earnings from a year earlier ...

Lofty expectations for US corporate profits mean that the flood of earnings reports due in the coming fortnight will play a particularly important role in setting the direction for Wall Street stocks, ...

Wall Street’s so-called fear gauge has dropped this week, as the U.S. stock market appeared relieved that Treasury yields retreated from their recent climb. The Cboe Volatility Index was down 3.5% on ...

Wall Street has been seesawing for weeks as traders tear up their forecasts for what the Fed will do with interest rates in ...

JPMorgan Chase stands head-and-shoulders above the rest of this group of largest U.S. banks by ROAA, while Morgan Stanley runs a pretty close second when its performance is measured by ROTCE. And with ...

Goldman Sachs Group Inc.'s Chief Executive David Solomon said he's "pleased" with the bank's "strong" results after the investment bank handily topped Wall Street estimates for its fourth-quarter ...

The S&P 500's 2.9% climb this week left it up 2% in January through Friday, according to FactSet data. The Invesco S&P 500 Equal Weight ETF RSP staged a larger 3.9% rally this week, for a year-to-date ...

Important earnings season ahead as investors look for positive signs that the US economy can continue to be resilient in 2025 ...

JPMorgan shares jumped on the bank's final financial results of 2024, climbing 2.6% before the bell.

Inflation is proving stickier than expected, which could cause Fed to hit pause button on more interest rate cuts.

NEW YORK — Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said ...